Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors
InSilico Medicine Hong Kong Limited
InSilico Medicine Hong Kong Limited
Verismo Therapeutics
SpringWorks Therapeutics, Inc.
IDEAYA Biosciences
Abramson Cancer Center at Penn Medicine
Nurix Therapeutics, Inc.
Context Therapeutics Inc.
Ascentage Pharma Group Inc.
Erasmus Medical Center
Suzhou Maximum Bio-tech Co., Ltd.
UTC Therapeutics Inc.